Skip to content

BPT-PCAS Trial

Breakthrough Platform Trial for Post Cardiac Arrest Syndrome: A Cluster Randomized Trial - Breakthrough Platform Trial for Post Cardiac Arrest Syndrome: A Cluster Randomized Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1060260027
Enrollment
1374
Registered
2026-06-02
Start date
2026-06-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients with cardiac arrest with persistent coma after ROSC and require intensive care adult cardiac arrest

Interventions

Head position (Adjustment of the bed backrest or whole-bed tilt) -Head elevation group (30-45 degree angle): head position maintained at 30-45 degree angle -Supine position group (0-10 degree angle):
Head position, Temperature control

Sponsors

Kawakita Kenya
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with return of spontaneous circulation (ROSC) after cardiac arrest who require intensive care management 2) Unconsciousness after ROSC (Glasgow Coma Scale motor score < 6) 3) 18 years or older

Exclusion criteria

Exclusion criteria: 1) Refusal of intensive care management 2) Extracorporeal cardiopulmonary resuscitation (ECPR) performed as cardiopulmonary resuscitation 3) Known or estimated pregnancy 4) Cardiac arrest (including suspected cases) due to intracerebral hemorrhage, subarachnoid hemorrhage, cerebral infarction, acute aortic dissection, or terminal cancer 5) Known chronic obstructive pulmonary disease with home oxygen therapy 6) Known cerebral performance category (CPC) of 3-4 or overall performance category (OPC) of 3-4 before cardiac arrest 7) Patients with a pre-existing do-not-attempt-resuscitation (DNAR) order at the time of cardiac arrest. 8) Anticipated early death 9) Consent not obtained or withdrawn by the participant or surrogate 10) Other reasons deemed inappropriate for participation by the investigator or subinvestigator

Design outcomes

Primary

MeasureTime frame
All-cause mortality at 90 days

Secondary

MeasureTime frame
-All-cause in-hospital mortality -Modified Rankin Scale (mRS) at hospital discharge, 30 days, and 90 days after admission

Contacts

Public ContactYoko Kataoka

Kagawa University Hospital

j-neuro@googlegroups.com+81-87-891-5677

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026